Serina Therapeutics got supportive feedback from the Food and Drug Administration for its trial design for a Parkinson's treatment. Shares climbed 33% to $7.50 in after-hours trading Monday.

We rate Endurance 4.6 out of 5 and name it the provider with the Best Comprehensive Coverage in 2025 based on cost and ...

Keurig Dr Pepper Inc. announced an $18 billion all-cash deal to acquire Dutch-based JDE Peet’s NV on Monday, a major bet on ...

Scentre, which owns and operates 42 Westfield branded shopping centers, raised its distribution to 17.72 Australian cents (11.5 U.S. cents) per security for the 12 months through December. That is 3% ...

Fortescue's underlying earnings before interest, tax, depreciation and amortization, or Ebitda, fell by 26% to US$7.94 billion, on a 15% drop in annual revenue. Its underlying Ebitda margin narrowed ...

Investment firm Thoma Bravo has agreed to buy call-center software company Verint for $2 billion in cash. Silicon Valley is putting more than $100 million into a network of political-action committees ...